Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Jan 1;90(1):183–187. doi: 10.1073/pnas.90.1.183

Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line.

E Fikrig 1, R Berland 1, M Chen 1, S Williams 1, L H Sigal 1, R A Flavell 1
PMCID: PMC45624  PMID: 7678336

Abstract

Antibodies in sera of 7 patients with neurologic manifestations of Lyme borreliosis and a monoclonal antibody (mAb H9724) to the flagellin of Borrelia burgdorferi have been shown to bind neural tissue. To identify the antibody binding site common to the B. burgdorferi flagellin and the neural tissue, we made recombinant fusion proteins expressing epitopes of flagellin. Antibodies in patients' sera and mAb H9724 bound within an 18-amino acid epitope (residues 208-225) in the central region of flagellin, whereas two other mAbs bound to epitopes mapping elsewhere in the protein. Antibodies in patients sera and mAb H9724 also bound to a human neuroblastoma cell line. Absorption of patients sera with a peptide, EGVQQEGAQQPA, corresponding to amino acids 213-224 of flagellin, inhibited binding to the neuroblastoma cell line. The data suggest that the immune response to a specific B-cell epitope within flagellin, shared by a human neuroblastoma cell line, may be involved in the pathogenesis of neuroborreliosis.

Full text

PDF
183

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aberer E., Brunner C., Suchanek G., Klade H., Barbour A., Stanek G., Lassmann H. Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol. 1989 Dec;26(6):732–737. doi: 10.1002/ana.410260608. [DOI] [PubMed] [Google Scholar]
  2. Baig S., Olsson T., Hansen K., Link H. Anti-Borrelia burgdorferi antibody response over the course of Lyme neuroborreliosis. Infect Immun. 1991 Mar;59(3):1050–1056. doi: 10.1128/iai.59.3.1050-1056.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baig S., Olsson T., Link H. Predominance of Borrelia burgdorferi specific B cells in cerebrospinal fluid in neuroborreliosis. Lancet. 1989 Jul 8;2(8654):71–74. doi: 10.1016/s0140-6736(89)90314-0. [DOI] [PubMed] [Google Scholar]
  4. Berland R., Fikrig E., Rahn D., Hardin J., Flavell R. A. Molecular characterization of the humoral response to the 41-kilodalton flagellar antigen of Borrelia burgdorferi, the Lyme disease agent. Infect Immun. 1991 Oct;59(10):3531–3535. doi: 10.1128/iai.59.10.3531-3535.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Collins C., Peltz G. Immunoreactive epitopes on an expressed recombinant flagellar protein of Borrelia burgdorferi. Infect Immun. 1991 Feb;59(2):514–520. doi: 10.1128/iai.59.2.514-520.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Craft J. E., Fischer D. K., Shimamoto G. T., Steere A. C. Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest. 1986 Oct;78(4):934–939. doi: 10.1172/JCI112683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gassmann G. S., Jacobs E., Deutzmann R., Göbel U. B. Analysis of the Borrelia burgdorferi GeHo fla gene and antigenic characterization of its gene product. J Bacteriol. 1991 Feb;173(4):1452–1459. doi: 10.1128/jb.173.4.1452-1459.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gassmann G. S., Kramer M., Göbel U. B., Wallich R. Nucleotide sequence of a gene encoding the Borrelia burgdorferi flagellin. Nucleic Acids Res. 1989 May 11;17(9):3590–3590. doi: 10.1093/nar/17.9.3590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hansen K., Cruz M., Link H. Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis. 1990 Jun;161(6):1194–1202. doi: 10.1093/infdis/161.6.1194. [DOI] [PubMed] [Google Scholar]
  10. Martin R., Ortlauf J., Sticht-Groh V., Bogdahn U., Goldmann S. F., Mertens H. G. Borrelia burgdorferi--specific and autoreactive T-cell lines from cerebrospinal fluid in Lyme radiculomyelitis. Ann Neurol. 1988 Oct;24(4):509–516. doi: 10.1002/ana.410240406. [DOI] [PubMed] [Google Scholar]
  11. Pachner A. R., Duray P., Steere A. C. Central nervous system manifestations of Lyme disease. Arch Neurol. 1989 Jul;46(7):790–795. doi: 10.1001/archneur.1989.00520430086023. [DOI] [PubMed] [Google Scholar]
  12. Pachner A. R., Itano A. Borrelia burgdorferi infection of the brain: characterization of the organism and response to antibiotics and immune sera in the mouse model. Neurology. 1990 Oct;40(10):1535–1540. doi: 10.1212/wnl.40.10.1535. [DOI] [PubMed] [Google Scholar]
  13. Pachner A. R., Steere A. C., Sigal L. H., Johnson C. J. Antigen-specific proliferation of CSF lymphocytes in Lyme disease. Neurology. 1985 Nov;35(11):1642–1644. doi: 10.1212/wnl.35.11.1642. [DOI] [PubMed] [Google Scholar]
  14. Preac Mursic V., Wilske B., Schierz G., Pfister H. W., Einhäupl K. Repeated isolation of spirochetes from the cerebrospinal fluid of a patient with meningoradiculitis Bannwarth. Eur J Clin Microbiol. 1984 Dec;3(6):564–565. doi: 10.1007/BF02013623. [DOI] [PubMed] [Google Scholar]
  15. Schneider T., Lange R., Rönspeck W., Weigelt W., Kölmel H. W. Prognostic B-cell epitopes on the flagellar protein of Borrelia burgdorferi. Infect Immun. 1992 Jan;60(1):316–319. doi: 10.1128/iai.60.1.316-319.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sears J. E., Fikrig E., Nakagawa T. Y., Deponte K., Marcantonio N., Kantor F. S., Flavell R. A. Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J Immunol. 1991 Sep 15;147(6):1995–2000. [PubMed] [Google Scholar]
  17. Sigal L. H. Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms. Semin Arthritis Rheum. 1989 Feb;18(3):151–167. doi: 10.1016/0049-0172(89)90058-9. [DOI] [PubMed] [Google Scholar]
  18. Sigal L. H. Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms. Semin Arthritis Rheum. 1989 Feb;18(3):151–167. doi: 10.1016/0049-0172(89)90058-9. [DOI] [PubMed] [Google Scholar]
  19. Sigal L. H., Tatum A. H. Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens. Neurology. 1988 Sep;38(9):1439–1442. doi: 10.1212/wnl.38.9.1439. [DOI] [PubMed] [Google Scholar]
  20. Steere A. C. Lyme disease. N Engl J Med. 1989 Aug 31;321(9):586–596. doi: 10.1056/NEJM198908313210906. [DOI] [PubMed] [Google Scholar]
  21. Van Voorhis W. C., Schlekewy L., Trong H. L. Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):5993–5997. doi: 10.1073/pnas.88.14.5993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES